This inventor holds 14 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignees: Saint-Gobain Placo S.a.s., Qualcomm Technologies International, Ltd., Rolls-Royce Corporation. Active years: 2017-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Derby, GB (2019)
- Melton Mowbray, GB (2022)
- Cambridge, GB (2017 - 2023)
- Coventry, GB (2020 - 2024)
Company Filing History:
4 out of 25 
3 out of 99 
3 out of 6,039 
Years Active: 2017-2024
Title: The Innovative Contributions of Nicholas G Jones in Cannabinoid Research
Introduction: Nicholas G Jones, an accomplished inventor based in Derby, GB, has made significant strides in the field of cannabinoid research, boasting nine patents to his name. His work focuses on the therapeutic applications of cannabinoids, specifically in the treatment of epilepsy, showcasing his commitment to advancing medical science.
Latest Patents: Jones' latest patents delve into the use of cannabidiolic acid (CBDA) as a treatment for epilepsy. This groundbreaking invention outlines the effectiveness of CBDA, particularly in managing generalized seizures, including tonic-clonic seizures. His patent emphasizes a highly purified extract of cannabis, wherein the CBDA content exceeds 60%, and in optimal cases, reaches over 98%. Notably, the invention includes the removal of other cannabinoids, such as tetrahydrocannabinol (THC) and tetrahydrocannabinol acid (THCA), enhancing the purity and potential efficacy of the treatment. Additionally, CBDA can also be synthetically produced, offering versatility in therapeutic application.
Career Highlights: Jones' professional journey includes significant contributions to renowned companies such as Qualcomm Technologies International and Rolls-Royce Corporation. His experience in these technology-driven environments has likely fueled his innovative approach to research and development in cannabinoid treatments.
Collaborations: Throughout his career, Jones has collaborated with fellow experts in the field, including Robin Heydon and Nicolas Guy Albert Graube. These collaborations underscore the importance of teamwork and interdisciplinary partnerships in advancing scientific research and innovation.
Conclusion: Nicholas G Jones stands out as a pioneering inventor whose work in cannabinoid research is poised to make a remarkable impact on the treatment of epilepsy. With his extensive patent portfolio and collaborative spirit, Jones continues to contribute meaningfully to the medical field, paving the way for new therapeutic avenues in the management of seizure disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile